[SCHEDULE 13G/A] Aimei Health Technology Co., Ltd Unit SEC Filing

Rhea-AI Filing Summary

W. R. Berkley Corporation and its subsidiary Berkley Insurance Company report beneficial ownership of 425,361 ordinary shares of Aimei Health Technology Co., Ltd (ordinary shares, $0.0001 par). That stake represents 6.9% of the company’s outstanding shares based on the issuer’s publicly reported total of 6,121,733 shares. The filing shows shared voting and shared dispositive power over the 425,361 shares rather than sole control.

The statement notes the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer. Reporting persons are organized in Delaware and list a Greenwich, CT address for their principal business office.

Positive

• Material institutional ownership disclosed: 425,361 shares representing 6.9% of the class
• Passive intent certified: Securities reported as held in the ordinary course and not for changing control

Negative

• None.

Insights

Financial Analyst

TL;DR Institutional investor disclosed a meaningful passive stake of 6.9% in Aimei Health, reported as shared voting/dispositive power.

The reported 425,361-share position is material relative to the issuer’s 6,121,733 outstanding shares and crosses the common 5% disclosure threshold, making it relevant to investors monitoring ownership concentration. The filing is on Schedule 13G-style terms, indicating a passive intent and explicit certification that the stake is not held to influence control. For valuation or governance implications, this signals increased institutional ownership but not an active takeover or proxy campaign.

Corporate Governance Expert

TL;DR A 6.9% holding filed on a passive schedule indicates meaningful influence potential but no declared control intent.

The document identifies both a parent company and an insurance subsidiary as reporting persons and records shared voting and dispositive authority, which can reflect custodial or pooled arrangements. Crucially, the filing includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing control. From a governance perspective, this is a material ownership disclosure that does not, by itself, trigger control-related obligations or defensive measures by the issuer.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Aimei Health Technology Co., Ltd

(Name of Issuer)

Ordinary Shares, par value $0.0001 per share

(Title of Class of Securities)

G01341109

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. G01341109

1

Names of Reporting Persons

W. R. Berkley Corporation

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 425,361.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 425,361.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

425,361.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP No. G01341109

1

Names of Reporting Persons

Berkley Insurance Company

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 425,361.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 425,361.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

425,361.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

IC, CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Aimei Health Technology Co., Ltd
(b)	Address of issuer's principal executive offices: 10 East 53rd Street, Suite 3001, New York, NY 10022
Item 2.
(a)	Name of person filing: The information required by Item 2(a) is set forth in Row 1 of the cover page hereto for each Reporting Person and is incorporated herein by reference for each such Reporting Person.
(b)	Address or principal business office or, if none, residence: The address of each Reporting Person is: 475 Steamboat Road Greenwich, CT 06830
(c)	Citizenship: The information required by Item 2(c) is set forth in Row 4 of the cover page hereto for each Reporting Person and is incorporated herein by reference for each such Reporting Person.
(d)	Title of class of securities: Ordinary Shares, par value $0.0001 per share
(e)	CUSIP No.: G01341109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page hereto for each Reporting Person and is incorporated herein by reference for each such Reporting Person. Calculation of the ownership percentage set forth in Row 11 is based on the Issuer's publicly available Form 10-Q filed May 14, 2025 for the quarter ending March 31, 2025, which states that the Issuer had issued and outstanding 6,121,733 Ordinary Shares as of May 14, 2025.
(b)	Percent of class:
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote:
	(ii) Shared power to vote or to direct the vote:
	(iii) Sole power to dispose or to direct the disposition of:
	(iv) Shared power to dispose or to direct the disposition of:
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99.1.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

W. R. Berkley Corporation

Signature:	By: /s/ Richard M. Baio
Name/Title:	Richard M. Baio, Executive Vice President and Chief Financial Officer
Date:	08/08/2025

Berkley Insurance Company

Signature:	By: /s/ Richard M. Baio
Name/Title:	Richard M. Baio, Executive Vice President and Treasurer
Date:	08/08/2025

FAQ

Who filed the Schedule 13G/A for Aimei Health Technology (AFJKU)?

The filing was made by W. R. Berkley Corporation and Berkley Insurance Company.

How many shares and what percentage of AFJKU does the filer own?

The reporting persons claim beneficial ownership of 425,361 shares, equal to 6.9% of the outstanding shares.

What class of security is reported in the filing for AFJKU?

The filing covers Ordinary Shares of Aimei Health Technology Co., Ltd, par value $0.0001 per share.

Does the filer claim intent to influence control of AFJKU?

No. The filing certifies the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer.

What voting and dispositive powers are reported?

The filings report 0 sole voting/dispositive power and 425,361 shared voting and shared dispositive power.